Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 31;15(5):2367-2371.
doi: 10.21037/jgo-24-37. Epub 2024 Oct 29.

BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy

Victor Lopez-Lopez #  1   2 , Ignacio Sánchez-Esquer #  1   2 , Pablo Ramírez  1   2 , Ricardo Robles-Campos  1   2
Affiliations
Editorial

BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy

Victor Lopez-Lopez et al. J Gastrointest Oncol. .
No abstract available

Keywords: Hepatocellular carcinoma (HCC); hepatic arterial infusion chemotherapy (HAIC); immunotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.org/article/view/10.21037/jgo-24-37/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Zhang TQ, Geng ZJ, Zuo MX, et al. Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study. Signal Transduct Target Ther 2023;8:413. 10.1038/s41392-023-01663-6 - DOI - PMC - PubMed
    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. 10.3322/caac.21660 - DOI - PubMed
    1. Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 2023;20:864-84. 10.1038/s41571-023-00825-3 - DOI - PubMed
    1. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 2022;76:681-93. 10.1016/j.jhep.2021.11.018 - DOI - PMC - PubMed
    1. Bruix J, Chan SL, Galle PR, et al. Systemic treatment of hepatocellular carcinoma: An EASL position paper. J Hepatol 2021;75:960-74. 10.1016/j.jhep.2021.07.004 - DOI - PubMed

LinkOut - more resources